IBDEI090 ; ; 18-NOV-2013
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;NOV 18, 2013
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,11893,0)
 ;;=282.61^^74^682^66
 ;;^UTILITY(U,$J,358.3,11893,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11893,1,4,0)
 ;;=4^282.61
 ;;^UTILITY(U,$J,358.3,11893,1,5,0)
 ;;=5^Hemoglobin S Disease
 ;;^UTILITY(U,$J,358.3,11893,2)
 ;;=^267981
 ;;^UTILITY(U,$J,358.3,11894,0)
 ;;=282.7^^74^682^65
 ;;^UTILITY(U,$J,358.3,11894,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11894,1,4,0)
 ;;=4^282.7
 ;;^UTILITY(U,$J,358.3,11894,1,5,0)
 ;;=5^Hemoglobin C Disease
 ;;^UTILITY(U,$J,358.3,11894,2)
 ;;=^87629
 ;;^UTILITY(U,$J,358.3,11895,0)
 ;;=283.9^^74^682^68
 ;;^UTILITY(U,$J,358.3,11895,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11895,1,4,0)
 ;;=4^283.9
 ;;^UTILITY(U,$J,358.3,11895,1,5,0)
 ;;=5^Hemolytic Anemia , Acquired
 ;;^UTILITY(U,$J,358.3,11895,2)
 ;;=^7071
 ;;^UTILITY(U,$J,358.3,11896,0)
 ;;=283.0^^74^682^69
 ;;^UTILITY(U,$J,358.3,11896,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11896,1,4,0)
 ;;=4^283.0
 ;;^UTILITY(U,$J,358.3,11896,1,5,0)
 ;;=5^Hemolytic Anemia, Autoimmune
 ;;^UTILITY(U,$J,358.3,11896,2)
 ;;=^7079
 ;;^UTILITY(U,$J,358.3,11897,0)
 ;;=282.9^^74^682^67
 ;;^UTILITY(U,$J,358.3,11897,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11897,1,4,0)
 ;;=4^282.9
 ;;^UTILITY(U,$J,358.3,11897,1,5,0)
 ;;=5^Hemolytic Anem, Heredit
 ;;^UTILITY(U,$J,358.3,11897,2)
 ;;=^56578
 ;;^UTILITY(U,$J,358.3,11898,0)
 ;;=283.19^^74^682^70
 ;;^UTILITY(U,$J,358.3,11898,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11898,1,4,0)
 ;;=4^283.19
 ;;^UTILITY(U,$J,358.3,11898,1,5,0)
 ;;=5^Hemolytic Anemia, Microang
 ;;^UTILITY(U,$J,358.3,11898,2)
 ;;=^293664
 ;;^UTILITY(U,$J,358.3,11899,0)
 ;;=280.9^^74^682^74
 ;;^UTILITY(U,$J,358.3,11899,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11899,1,4,0)
 ;;=4^280.9
 ;;^UTILITY(U,$J,358.3,11899,1,5,0)
 ;;=5^Iron Defic Anemia(Unspecified)
 ;;^UTILITY(U,$J,358.3,11899,2)
 ;;=^276946
 ;;^UTILITY(U,$J,358.3,11900,0)
 ;;=285.1^^74^682^72
 ;;^UTILITY(U,$J,358.3,11900,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11900,1,4,0)
 ;;=4^285.1
 ;;^UTILITY(U,$J,358.3,11900,1,5,0)
 ;;=5^Iron Defic Anemia Due To Acute Blood Loss
 ;;^UTILITY(U,$J,358.3,11900,2)
 ;;=^267986
 ;;^UTILITY(U,$J,358.3,11901,0)
 ;;=280.0^^74^682^73
 ;;^UTILITY(U,$J,358.3,11901,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11901,1,4,0)
 ;;=4^280.0
 ;;^UTILITY(U,$J,358.3,11901,1,5,0)
 ;;=5^Iron Defic Anemia Due To Chronic Blood Loss
 ;;^UTILITY(U,$J,358.3,11901,2)
 ;;=^267971
 ;;^UTILITY(U,$J,358.3,11902,0)
 ;;=281.9^^74^682^92
 ;;^UTILITY(U,$J,358.3,11902,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11902,1,4,0)
 ;;=4^281.9
 ;;^UTILITY(U,$J,358.3,11902,1,5,0)
 ;;=5^Nutritional Anemia
 ;;^UTILITY(U,$J,358.3,11902,2)
 ;;=^123801
 ;;^UTILITY(U,$J,358.3,11903,0)
 ;;=281.0^^74^682^109
 ;;^UTILITY(U,$J,358.3,11903,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11903,1,4,0)
 ;;=4^281.0
 ;;^UTILITY(U,$J,358.3,11903,1,5,0)
 ;;=5^Vit B12 Deficiency (Pernicious Anemia)
 ;;^UTILITY(U,$J,358.3,11903,2)
 ;;=^7161
 ;;^UTILITY(U,$J,358.3,11904,0)
 ;;=282.60^^74^682^99
 ;;^UTILITY(U,$J,358.3,11904,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11904,1,4,0)
 ;;=4^282.60
 ;;^UTILITY(U,$J,358.3,11904,1,5,0)
 ;;=5^Sickle-Cell Anemia
 ;;^UTILITY(U,$J,358.3,11904,2)
 ;;=^7188
 ;;^UTILITY(U,$J,358.3,11905,0)
 ;;=282.62^^74^682^100
 ;;^UTILITY(U,$J,358.3,11905,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11905,1,4,0)
 ;;=4^282.62
 ;;^UTILITY(U,$J,358.3,11905,1,5,0)
 ;;=5^Sickle-Cell With Crisis
 ;;^UTILITY(U,$J,358.3,11905,2)
 ;;=^267982
 ;;^UTILITY(U,$J,358.3,11906,0)
 ;;=281.1^^74^682^110
 ;;^UTILITY(U,$J,358.3,11906,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11906,1,4,0)
 ;;=4^281.1
 ;;^UTILITY(U,$J,358.3,11906,1,5,0)
 ;;=5^Vit B12 Deficiency(Dietary)
 ;;^UTILITY(U,$J,358.3,11906,2)
 ;;=^267974
 ;;^UTILITY(U,$J,358.3,11907,0)
 ;;=286.7^^74^682^44
 ;;^UTILITY(U,$J,358.3,11907,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11907,1,4,0)
 ;;=4^286.7
 ;;^UTILITY(U,$J,358.3,11907,1,5,0)
 ;;=5^Coagulation Defect(Any),Acquired
 ;;^UTILITY(U,$J,358.3,11907,2)
 ;;=^2235
 ;;^UTILITY(U,$J,358.3,11908,0)
 ;;=289.9^^74^682^106
 ;;^UTILITY(U,$J,358.3,11908,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11908,1,4,0)
 ;;=4^289.9
 ;;^UTILITY(U,$J,358.3,11908,1,5,0)
 ;;=5^Thrombocytosis, Essential
 ;;^UTILITY(U,$J,358.3,11908,2)
 ;;=^55344
 ;;^UTILITY(U,$J,358.3,11909,0)
 ;;=451.9^^74^682^107
 ;;^UTILITY(U,$J,358.3,11909,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11909,1,4,0)
 ;;=4^451.9
 ;;^UTILITY(U,$J,358.3,11909,1,5,0)
 ;;=5^Thrombophlebitis 
 ;;^UTILITY(U,$J,358.3,11909,2)
 ;;=^93357
 ;;^UTILITY(U,$J,358.3,11910,0)
 ;;=446.6^^74^682^108
 ;;^UTILITY(U,$J,358.3,11910,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11910,1,4,0)
 ;;=4^446.6
 ;;^UTILITY(U,$J,358.3,11910,1,5,0)
 ;;=5^Thrombotic Thrombocytopenic Purpura(Ttp)
 ;;^UTILITY(U,$J,358.3,11910,2)
 ;;=^119061
 ;;^UTILITY(U,$J,358.3,11911,0)
 ;;=286.4^^74^682^111
 ;;^UTILITY(U,$J,358.3,11911,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11911,1,4,0)
 ;;=4^286.4
 ;;^UTILITY(U,$J,358.3,11911,1,5,0)
 ;;=5^Von Willebrand'S Disease
 ;;^UTILITY(U,$J,358.3,11911,2)
 ;;=^127267
 ;;^UTILITY(U,$J,358.3,11912,0)
 ;;=204.00^^74^682^4
 ;;^UTILITY(U,$J,358.3,11912,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11912,1,4,0)
 ;;=4^204.00
 ;;^UTILITY(U,$J,358.3,11912,1,5,0)
 ;;=5^All, W/O Remission
 ;;^UTILITY(U,$J,358.3,11912,2)
 ;;=^267521
 ;;^UTILITY(U,$J,358.3,11913,0)
 ;;=204.01^^74^682^3
 ;;^UTILITY(U,$J,358.3,11913,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11913,1,4,0)
 ;;=4^204.01
 ;;^UTILITY(U,$J,358.3,11913,1,5,0)
 ;;=5^All, In Remission
 ;;^UTILITY(U,$J,358.3,11913,2)
 ;;=^267522
 ;;^UTILITY(U,$J,358.3,11914,0)
 ;;=204.10^^74^682^41
 ;;^UTILITY(U,$J,358.3,11914,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11914,1,4,0)
 ;;=4^204.10
 ;;^UTILITY(U,$J,358.3,11914,1,5,0)
 ;;=5^Cll, W/O Remission
 ;;^UTILITY(U,$J,358.3,11914,2)
 ;;=^267523
 ;;^UTILITY(U,$J,358.3,11915,0)
 ;;=204.11^^74^682^40
 ;;^UTILITY(U,$J,358.3,11915,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11915,1,4,0)
 ;;=4^204.11
 ;;^UTILITY(U,$J,358.3,11915,1,5,0)
 ;;=5^Cll, In Remission
 ;;^UTILITY(U,$J,358.3,11915,2)
 ;;=^267524
 ;;^UTILITY(U,$J,358.3,11916,0)
 ;;=201.90^^74^682^71
 ;;^UTILITY(U,$J,358.3,11916,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11916,1,4,0)
 ;;=4^201.90
 ;;^UTILITY(U,$J,358.3,11916,1,5,0)
 ;;=5^Hodgkin'S Lymphoma, Unpsec Type & Site
 ;;^UTILITY(U,$J,358.3,11916,2)
 ;;=^267430
 ;;^UTILITY(U,$J,358.3,11917,0)
 ;;=785.6^^74^682^77
 ;;^UTILITY(U,$J,358.3,11917,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11917,1,4,0)
 ;;=4^785.6
 ;;^UTILITY(U,$J,358.3,11917,1,5,0)
 ;;=5^Lymphadenopathy
 ;;^UTILITY(U,$J,358.3,11917,2)
 ;;=^72368
 ;;^UTILITY(U,$J,358.3,11918,0)
 ;;=200.20^^74^682^78
 ;;^UTILITY(U,$J,358.3,11918,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11918,1,4,0)
 ;;=4^200.20
 ;;^UTILITY(U,$J,358.3,11918,1,5,0)
 ;;=5^Lymphoma, Burkitt'S, Unspecified Sites
 ;;^UTILITY(U,$J,358.3,11918,2)
 ;;=^17529
 ;;^UTILITY(U,$J,358.3,11919,0)
 ;;=202.00^^74^682^80
 ;;^UTILITY(U,$J,358.3,11919,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11919,1,4,0)
 ;;=4^202.00
 ;;^UTILITY(U,$J,358.3,11919,1,5,0)
 ;;=5^Lymphoma, Low-Grade, Unspec Site
 ;;^UTILITY(U,$J,358.3,11919,2)
 ;;=^72606
 ;;^UTILITY(U,$J,358.3,11920,0)
 ;;=200.10^^74^682^79
 ;;^UTILITY(U,$J,358.3,11920,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11920,1,4,0)
 ;;=4^200.10
 ;;^UTILITY(U,$J,358.3,11920,1,5,0)
 ;;=5^Lymphoma, Int Or High Grade, Unspec Site
 ;;^UTILITY(U,$J,358.3,11920,2)
 ;;=^175886
 ;;^UTILITY(U,$J,358.3,11921,0)
 ;;=273.3^^74^682^81
 ;;^UTILITY(U,$J,358.3,11921,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11921,1,4,0)
 ;;=4^273.3
 ;;^UTILITY(U,$J,358.3,11921,1,5,0)
 ;;=5^Macroglobulinemia
 ;;^UTILITY(U,$J,358.3,11921,2)
 ;;=^73013
 ;;^UTILITY(U,$J,358.3,11922,0)
 ;;=203.00^^74^682^90
 ;;^UTILITY(U,$J,358.3,11922,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11922,1,4,0)
 ;;=4^203.00
 ;;^UTILITY(U,$J,358.3,11922,1,5,0)
 ;;=5^Multiple Myeloma W/O Rem
 ;;^UTILITY(U,$J,358.3,11922,2)
 ;;=^267514
 ;;^UTILITY(U,$J,358.3,11923,0)
 ;;=203.01^^74^682^89
 ;;^UTILITY(U,$J,358.3,11923,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11923,1,4,0)
 ;;=4^203.01
 ;;^UTILITY(U,$J,358.3,11923,1,5,0)
 ;;=5^Multiple Myeloma In Remission
 ;;^UTILITY(U,$J,358.3,11923,2)
 ;;=^267515
 ;;^UTILITY(U,$J,358.3,11924,0)
 ;;=238.6^^74^682^93
 ;;^UTILITY(U,$J,358.3,11924,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11924,1,4,0)
 ;;=4^238.6
 ;;^UTILITY(U,$J,358.3,11924,1,5,0)
 ;;=5^Plasmacytoma Nos
 ;;^UTILITY(U,$J,358.3,11924,2)
 ;;=^81973
 ;;^UTILITY(U,$J,358.3,11925,0)
 ;;=205.00^^74^682^6
 ;;^UTILITY(U,$J,358.3,11925,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11925,1,4,0)
 ;;=4^205.00
 ;;^UTILITY(U,$J,358.3,11925,1,5,0)
 ;;=5^Aml, W/O Remission
 ;;^UTILITY(U,$J,358.3,11925,2)
 ;;=^267531
 ;;^UTILITY(U,$J,358.3,11926,0)
 ;;=205.01^^74^682^5
 ;;^UTILITY(U,$J,358.3,11926,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11926,1,4,0)
 ;;=4^205.01
 ;;^UTILITY(U,$J,358.3,11926,1,5,0)
 ;;=5^Aml, In Remission
 ;;^UTILITY(U,$J,358.3,11926,2)
 ;;=^267532
 ;;^UTILITY(U,$J,358.3,11927,0)
 ;;=205.10^^74^682^43
 ;;^UTILITY(U,$J,358.3,11927,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11927,1,4,0)
 ;;=4^205.10
 ;;^UTILITY(U,$J,358.3,11927,1,5,0)
 ;;=5^Cml, W/O Remission
 ;;^UTILITY(U,$J,358.3,11927,2)
 ;;=^267533
 ;;^UTILITY(U,$J,358.3,11928,0)
 ;;=205.11^^74^682^42
 ;;^UTILITY(U,$J,358.3,11928,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11928,1,4,0)
 ;;=4^205.11
 ;;^UTILITY(U,$J,358.3,11928,1,5,0)
 ;;=5^Cml, In Remission
 ;;^UTILITY(U,$J,358.3,11928,2)
 ;;=^267534
 ;;^UTILITY(U,$J,358.3,11929,0)
 ;;=289.0^^74^682^45
 ;;^UTILITY(U,$J,358.3,11929,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11929,1,4,0)
 ;;=4^289.0
 ;;^UTILITY(U,$J,358.3,11929,1,5,0)
 ;;=5^Erthryocytosis, Secondary
 ;;^UTILITY(U,$J,358.3,11929,2)
 ;;=^186856
